Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index.
about
Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use DisordersComparison of Homeless and Non-Homeless Problem Drug Users Recruited from Primary Care Safety-Net ClinicsClinician empathy is associated with differences in patient-clinician communication behaviors and higher medication self-efficacy in HIV care.Association between Genotype of the Serotonin Transporter-Linked Polymorphic Region of the Serotonin Transporter Gene and Age of Onset of Methamphetamine Use: a Preliminary Analysis.Computer-enhanced interventions for drug use and HIV risk in the emergency room: preliminary results on psychological precursors of behavior change.Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial.Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.Patient Pre-Treatment Expectations Do Not Predict Cocaine Use Outcomes: Data From Four Clinical TrialsA two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorderRandomized clinical trial of the effects of screening and brief intervention for illicit drug use: the Life Shift/Shift Gears study.Addiction Severity Index (ASI) summary scores: comparison of the Recent Status Scores of the ASI-6 and the Composite Scores of the ASI-5."We'll do this together": the role of the first person plural in fostering partnership in patient-physician relationships.Extended-release naltrexone opioid treatment at jail reentry (XOR)Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study.Medical and Mental Health Status Among Drug Dependent Patients Participating in a Smoking Cessation Treatment StudyIs level of exposure to a 12-step facilitation therapy associated with treatment outcome?Unhealthy substance-use behaviors as symptom-related self-care in persons with HIV/AIDSAn Examination of the First Oxford House in the UK: A Preliminary Investigation.Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: the ACHIEVE trialRandomized trial of intensive motivational interviewing for methamphetamine dependence.Correlates of Recent and Lifetime Aggression among Veterans with Co-Occurring PTSD and Substance Use Disorders.Prescription medication misuse among HIV-infected individuals taking antiretroviral therapyImproving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics.Substance use and the quality of patient-provider communication in HIV clinics.Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.Evaluating Alternative Aftercare Models for Ex-Offenders.Predictors of HIV-risk sexual behavior: examining lifetime sexual and physical abuse histories in relation to substance use and psychiatric problem severity among ex-offendersRecovery resources and psychiatric severity among persons with substance use disorders.Psychiatric severity and HIV-risk sexual behaviors among persons with substance use disorders.EFFECT OF JOB SKILLS TRAINING ON EMPLOYMENT AND JOB SEEKING BEHAVIORS IN AN AMERICAN INDIAN SUBSTANCE ABUSE TREATMENT SAMPLEBuprenorphine tapering schedule and illicit opioid use.Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trialThe role of cultural distance between patient and provider in explaining racial/ethnic disparities in HIV care.A mixed methods study of patient-provider communication about opioid analgesics.The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037)A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorderA Randomized Controlled Trial Comparing Integrated Cognitive Behavioral Therapy Versus Individual Addiction Counseling for Co-occurring Substance Use and Posttraumatic Stress Disorders.
P2860
Q27013929-84F1A0D1-3D26-4E36-A5B4-5473190CF12DQ28830525-9220CC10-A6B1-4CBD-B1ED-97763B63F669Q30278645-95E260BB-2EAA-4DE3-9FC2-72907D5E907DQ30432906-5522D2F9-3090-44E3-AAC5-95CFD18DB666Q30572035-1BEF528D-0F30-4A19-AEA3-473E03C66CAFQ30667437-0C22164E-5C0B-4703-863F-E4F7E9E72354Q30854873-4392A1EE-9B9B-4069-BE5D-DC11E1073257Q31111287-B39994FC-E21B-481D-AC01-52A4BA5D2D86Q33656107-DEEB4A33-588F-411A-8A92-4A8B31AEEBDBQ33712846-08D180A6-1250-4FAB-BACE-F6C0DB17BCFFQ33724620-1D8841C6-FF4E-445D-AE1E-B79E88734DDAQ33730840-CEF730D7-B18F-46D1-9556-93E3BEDFFACCQ33755501-7758CD9A-BC28-41CC-A7A8-51E48B6109F3Q33760418-4D2B9EFC-680A-4E26-9B7E-CBA43B8B0345Q33984533-39253858-CBF4-43B1-966E-31CBB87BBAC4Q34067017-E11A7BA3-3531-4330-AEDE-E888D4903220Q34263901-10311ECF-8C05-4A28-912A-BDF4C4372DB7Q34433559-23A787CF-C136-4E5E-9CD0-8683B5F10581Q34468141-8E6649E1-A1C6-4B5C-9F68-BFD9676856D7Q34473977-FD318A1A-B22E-4C96-A72A-5C5C2F33584BQ34555856-85608245-3597-4A1C-8E7F-6F73323B6168Q34602717-E3C15AFB-123D-4FD0-99B2-0AAF59B04321Q34732952-27BEDCD4-D14B-4FE7-95DE-F4F19C2CDA18Q34774846-3AD60CDD-D240-4B12-9811-CE722BE8EDB8Q34798733-58236693-055C-45BB-962F-43312D2C8874Q34817072-17BFFF2C-B4CF-433D-94BF-3397DB82EA60Q35018219-4CE5D645-1AA3-4095-912B-5E097B9BEE62Q35018710-94461A1A-0B2B-4802-B0E8-D736AC3FB0D3Q35027957-7C0E4EDE-5655-4E3C-9400-0DE4EDCC0E50Q35079410-FB77F8E8-6478-4CA8-B594-ED8DA42B03FDQ35138557-68B7AA33-27F9-4F77-8845-74B6A9E5F545Q35147170-C551AED7-C41F-4F25-ACAA-4774C4850AFAQ35189633-E3E8A628-1A1B-4D15-926C-80740CB9A0E0Q35318875-B7AB81A0-B859-45EF-AFE3-46F9595FAF1EQ35354161-EE32D0EE-4C40-422D-B72D-9822415E1820Q35563511-F6725011-3EC8-4ABE-B171-6226BEB349A2Q35726267-7C7365B6-5DD6-40DC-B443-5413B5C78086Q35742096-759E5883-B055-44E3-8A43-EC6B9F0D3026Q35772387-065893B0-D98B-457F-9B0E-F7DD7BD02AC6Q35786431-AC52E7A0-3695-4075-B99B-B14FBCA3E951
P2860
Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Initial evidence for the relia ...... the Addiction Severity Index.
@en
Initial evidence for the relia ...... the Addiction Severity Index.
@nl
type
label
Initial evidence for the relia ...... the Addiction Severity Index.
@en
Initial evidence for the relia ...... the Addiction Severity Index.
@nl
prefLabel
Initial evidence for the relia ...... the Addiction Severity Index.
@en
Initial evidence for the relia ...... the Addiction Severity Index.
@nl
P2093
P1476
Initial evidence for the relia ...... the Addiction Severity Index.
@en
P2093
A Thomas McLellan
Arthur I Alterman
John S Cacciola
Kevin G Lynch
Yi-Ting Lin
P304
P356
10.1016/J.DRUGALCDEP.2006.09.002
P577
2006-10-11T00:00:00Z